Clinical Outcomes in Acute Myeloid Leukemia (AML) Patients (pts) Carrying Isocitrate Dehydrogenase (IDH1-2) Mutations Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HCT)

Transplantation and cellular therapy(2021)

引用 0|浏览8
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要